[ad_1]
DUBLIN, May 11, 2020 / PRNewswire / – The report “2020 Coronavirus Vaccine Pipeline Assessment (COVID-19)” has been added to ResearchAndMarkets.com’s offering. “data-reactid =” 12 “>DUBLIN, May 11, 2020 / PRNewswire / – The report “2020 Coronavirus Vaccine Pipeline Assessment (COVID-19)” has been added to ResearchAndMarkets.com’s offering.
Research and markets logo
This report provides a comprehensive analysis of the global market for high-growth, rapidly evolving Coronavirus (COVID-19) vaccines. The report provides the most up-to-date industry data on the current market situation for the Coronavirus vaccine.
The report explores a detailed analysis of the introduction of the coronavirus, the characteristics of the pathogen, the signs and symptoms, transmission and prevention. It also evaluates vaccines developed against MERS-CoV and SARS-CoV. The report reviews a clear idea of funding for coronavirus vaccine research.
The report also provides complete information on clinical trial recruitment statement by phase, trial status, name of study sponsor, and study phase. The report investigates detailed insights into countries, territories, or areas with laboratory-confirmed Coronavirus cases and deaths. The key trends in terms of partnership and collaboration agreements are discussed in detail.
The report concludes with profiles of leading vaccine developers in the global coronavirus vaccine market. Key players are evaluated on various parameters, such as the business overview, the promising vaccine in clinical development, and recent development.
Oxford University
9.1.1 Business overview
9.1.2 Promising coronavirus vaccines in clinical development
9.1.3 Recent development
9.2 Clover Biopharmaceuticals / Dynavax / GlaxoSmithKline
9.3 Heat Biologics Inc./University of Miami
9.4 Inovio Pharmaceuticals Inc
9.5 Janssen Pharmaceutical
9.6 Sanofi Pasteur / GlaxoSmithKline (GSK)
9.7 Modern / NIAID
9.8 Novavax
9.9 Sanofi Pasteur / Translate Bio Inc.
9.10 Vaxart Inc.
9.11 Altimmune
9.12 Medicago
9.13 BioNTech / Pfizer / Fosun Pharma
9.14 GeoVax / BravoVax
9.15 Arcturus / Duke-NUS Therapeutics
9.16 CanSino Biological Inc / Beijing Institute of Biotechnology
9.17 Takis Biotech / Applied DNA Sciences / Evvivax
9.18 Cobra Biologics /Karolinska Institute
9.19 Zydus Cadila
9.20 Codagenix / Whey Institute of India
9.21 Greffex
9.22 ExpreS2ion Biotechnologies ApS
9.23 Vaxil Bio Therapeutics
9.24 Flow Pharma Inc.
9.25 AJ vaccines
9.26 Generex Biotechnology / EpiVax
9.27 Immune therapy / EpiVax / PharmaJet
9.28 iBio Inc / CC-Pharming Ltd / Infectious Disease Research Institute
9.29 VIDO-InterVac /Saskatchewan University/ International Vaccine Institute
9.30 Tonix Pharmaceuticals / Southern Research
9.31 IAVI / Batavia Biosciences
9.32 Curevac
9.33 Imophoron Ltd / University of Bristol board
9.34 BioNet Asia
9.35 Sinovac / Dynavax
9.36 BIOCAD
9.37 University of Pittsburgh“data-reactid =” 47 “>9. Analysis of key vaccine developers
9.1 Oxford University
9.1.1 Business overview
9.1.2 Promising coronavirus vaccines in clinical development
9.1.3 Recent development
9.2 Clover Biopharmaceuticals / Dynavax / GlaxoSmithKline
9.3 Heat Biologics Inc./University of Miami
9.4 Inovio Pharmaceuticals Inc
9.5 Janssen Pharmaceutical
9.6 Sanofi Pasteur / GlaxoSmithKline (GSK)
9.7 Modern / NIAID
9.8 Novavax
9.9 Sanofi Pasteur / Translate Bio Inc.
9.10 Vaxart Inc.
9.11 Altimmune
9.12 Medicago
9.13 BioNTech / Pfizer / Fosun Pharma
9.14 GeoVax / BravoVax
9.15 Arcturus / Duke-NUS Therapeutics
9.16 CanSino Biological Inc / Beijing Institute of Biotechnology
9.17 Takis Biotech / Applied DNA Sciences / Evvivax
9.18 Cobra Biologics /Karolinska Institute
9.19 Zydus Cadila
9.20 Codagenix / Whey Institute of India
9.21 Greffex
9.22 ExpreS2ion Biotechnologies ApS
9.23 Vaxil Bio Therapeutics
9.24 Flow Pharma Inc.
9.25 AJ vaccines
9.26 Generex Biotechnology / EpiVax
9.27 Immune therapy / EpiVax / PharmaJet
9.28 iBio Inc / CC-Pharming Ltd / Infectious Disease Research Institute
9.29 VIDO-InterVac /Saskatchewan University/ International Vaccine Institute
9.30 Tonix Pharmaceuticals / Southern Research
9.31 IAVI / Batavia Biosciences
9.32 Curevac
9.33 Imophoron Ltd / University of Bristol board
9.34 BioNet Asia
9.35 Sinovac / Dynavax
9.36 BIOCAD
9.37 University of Pittsburgh
